awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36304331-60AA06C8-AC90-4028-A445-24F52674C2DD
Q36304331-60AA06C8-AC90-4028-A445-24F52674C2DD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36304331-60AA06C8-AC90-4028-A445-24F52674C2DD
Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk--where are we now?
P2860
Q36304331-60AA06C8-AC90-4028-A445-24F52674C2DD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36304331-60AA06C8-AC90-4028-A445-24F52674C2DD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d6f93cc0be53c876ab5eebd0c26d3be449027f53
P2860
Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation: the Nonsteroidal Anti-Inflammatory Drugs in Unstable Angina Treatment-2 (NUT-2) pilot study